Results 41 to 50 of about 29,991,050 (179)

Antigen-Down PEC Immunosensor for CYFRA21‑1 Detection Based on Photocurrent Polarity Switching Strategy

, 2022
In this work, an antigen-down photoelectrochemical (PEC) immunosensor based on a signal polarity switching strategy for the detection of cytokeratin 19 fragment 21-1 (CYFRA21-1) was proposed.
Jinxiu Zhao (4507333), Xiang Ren (358465), Xiaodong Xue (582390), Huangxian Ju (392237), Jinhuan Zhang (740758), Hongmin Ma (625034), Qin Wei (1482154), Yizhen Du (12371752)   +7 more
core   +1 more source

Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer

The International Journal of Biological Markers, 2019
From January 2018 to May 2018, 108 patients with thoracic esophageal cancer underwent esophagectomy with two- to three-field lymph node dissection.
Xinyu Mei, Xiaodong Zhu, Lei Zuo, Hanran Wu, Mingfa Guo, Changqing Liu   +5 more
doaj   +1 more source

Serum CYFRA21-1 as an effective tumor biomarker for patients with nasopharyngeal carcinoma

Neoplasma, 2015
We investigated if the serum cytokeratin 19 fragment 21.1 (CYFRA21-1) level was elevated in nasopharyngeal carcinoma (NPC) and can function as a biomarker for detection and monitoring of NPC. Three hundred and one study subjects were divided into two groups: the NPC group (n=126) and healthy control group (n=175).
X M, Song, S Z, Wang, Z J, Wang, W J, Cao, J, L, F, Chen   +5 more
openaire   +3 more sources

Serum cyfra21-1 as a biomarker in patients with nonsmall cell lung cancer

Journal of Cancer Research and Therapeutics, 2014
The purpose of this retrospective study was to evaluate the clinical value of serum cytokeratin-19-fragment (cyfra21-1) as a biomarker in nonsmall cell lung cancer (NSCLC).Sixty-six patients with NSCLC and 48 cases with benign lung disease were retrospectively analyzed in the department of thoracic surgery in our hospital.
Hongjie, Zhao, Xuejun, Shi, Jinbo, Liu, Zhengang, Chen, Guangshun, Wang   +4 more
openaire   +2 more sources

A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study

Life, 2021
Radon is a major cause of lung cancer (LC) deaths among non-smokers worldwide. However, no serum biomarker for screening of LC risk in high residential radon (HRR) areas is available. Therefore, the aim of this study was to determine diagnostic values of
Narongchai Autsavapromporn, Pitchayaponne Klunklin, Imjai Chitapanarux, Churdsak Jaikang, Busyamas Chewaskulyong, Patumrat Sripan, Masahiro Hosoda, Shinji Tokonami   +7 more
doaj   +1 more source

CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis

Genetics and Molecular Research, 2015
The proteolytic region of cytokeratin-19, referred to as CYFRA21-1, is a soluble molecule present in the serum and other body fluids, and is considered a tumor marker in several neoplastic diseases. To examine whether urinary or serum samples containing CYFRA21-1 can be used as biomarkers for bladder cancer, we conducted a comprehensive meta-analysis ...
L I, Kuang, W J, Song, H M, Qing, S, Yan, F L, Song   +4 more
openaire   +2 more sources

Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines

Lung Cancer, 2000
The CYFRA 21-1 assay which detects cytokeratin 19 (CK19) fragment is widely used as a tumor marker for lung cancer. However, the reason why some lung cancer cell lines release CK19 fragment in culture supernatants and others do not, remains unclear. It was hypothesized that the release of CK19 fragment may be elucidated by the expression of mRNA for ...
K, Dohmoto, S, Hojo, J, Fujita, Y, Ueda, S, Bandoh, Y, Yamaji, Y, Ohtsuki, N, Dobashi, J, Takahara   +8 more
openaire   +3 more sources

Growth Differentiation Factor 15 as a Cerebrospinal Fluid Biomarker for the Diagnosis and Prognosis of Leptomeningeal Metastasis

Annals of Neurology, EarlyView.
Objective As leptomeningeal metastasis (LM) has a poor prognosis, reliable cerebrospinal fluid (CSF) diagnostic biomarkers are urgently needed. This study evaluated the diagnostic value of CSF growth differentiation factor 15 (GDF15) in LM from lung adenocarcinoma (LUAD) and breast cancer (BC).
Haoyu Ruan, Jie Li, Fuhai Wang, Lei Zhang, Jie Luo, Yuan Mu, Ting Wang, Yuqing Wu, Jingping Liu, Yunyun Ning, Xuan Deng, Ming Guan, Jian Xu   +12 more
wiley   +1 more source

Interface‐Engineered MXene/g‐C3N4 Heterostructures for Energy and Environmental Applications

EcoEnergy, EarlyView.
This review highlights how interface engineering in MXene/g‐C3N4 heterostructures regulates charge transfer, band alignment, and surface chemistry, enabling broad applications in photocatalytic conversion, environmental remediation, energy storage, and multifunctional sensing/therapy. ABSTRACT Two‐dimensional MXene/g‐C3N4 heterostructures have recently
Feng Wang, Geng Liu, Xiaoqiang An
wiley   +1 more source

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

FlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu, Yubing Hu, Dong Wang, Ben Zhong Tang   +3 more
wiley   +1 more source